Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies

被引:26
作者
Hernandez, Carlos [1 ]
Arasanz, Hugo [1 ,2 ]
Chocarro, Luisa [1 ]
Bocanegra, Ana [1 ]
Zuazo, Miren [1 ]
Fernandez-Hinojal, Gonzalo [2 ]
Blanco, Ester [1 ]
Vera, Ruth [2 ]
Escors, David [1 ]
Kochan, Grazyna [1 ]
机构
[1] IdISNA, UPNA, Biomed Res Ctr Navarrabiomed, Oncoimmunol Grp, Irunlarrea 3, Pamplona 31008, Spain
[2] IdISNA, Complejo Hosp Navarra, Dept Oncol, Irunlarrea 3, Pamplona 31008, Spain
关键词
immunotherapy; immune checkpoint inhibitors; systemic blood subsets; CD4(+); CD8(+); MDSCs; MISMATCH REPAIR DEFICIENCY; MEMORY T-CELLS; PERIPHERAL-BLOOD; PD-1; BLOCKADE; CLINICAL-SIGNIFICANCE; IPILIMUMAB TREATMENT; PREDICTS RESPONSE; HYPERPROGRESSION; LYMPHOCYTES; INCREASES;
D O I
10.3390/ijms21072411
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of cancer immunotherapy in the last decade has followed a vertiginous rhythm. Nowadays, immune checkpoint inhibitors (ICI) which include anti-CTLA4, anti-PD-1 and anti-PD-L1 antibodies are in clinical use for the treatment of numerous cancers. However, approximately only a third of the patients benefit from ICI therapies. Many efforts have been made for the identification of biomarkers allowing patient stratification into potential responders and progressors before the start of ICI therapies or for monitoring responses during treatment. While much attention is centered on biomarkers from the tumor microenvironment, in many cases biopsies are not available. The identification of systemic immune cell subsets that correlate with responses could provide promising biomarkers. Some of them have been reported to influence the response to ICI therapies, such as proliferation and activation status of CD8 and CD4 T cells, the expression of immune checkpoints in peripheral blood cells and the relative numbers of immunosuppressive cells such as regulatory T cells and myeloid-derived suppressor cells. In addition, the profile of soluble factors in plasma samples could be associated to response or tumor progression. Here we will review the cellular subsets associated to response or progression in different studies and discuss their accuracy in diagnosis.
引用
收藏
页数:13
相关论文
共 63 条
[1]   Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics [J].
Arasanz, Hugo ;
Zuazo, Miren ;
Bocanegra, Ana ;
Gato, Maria ;
Martinez-Aguillo, Maite ;
Morilla, Idoia ;
Fernandez, Gonzalo ;
Hernandez, Berta ;
Lopez, Paul ;
Alberdi, Nerea ;
Hernandez, Carlos ;
Chocarro, Luisa ;
Teijeira, Lucia ;
Vera, Ruth ;
Kochan, Grazyna ;
Escors, David .
CANCERS, 2020, 12 (02)
[2]   Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer [J].
Bagley, Stephen J. ;
Kothari, Shawn ;
Aggarwal, Charu ;
Bauml, Joshua M. ;
Alley, Evan W. ;
Evans, Tracey L. ;
Kosteva, John A. ;
Ciunci, Christine A. ;
Gabriel, Peter E. ;
Thompson, Jeffrey C. ;
Stonehouse-Lee, Susan ;
Sherry, Victoria E. ;
Gilbert, Elizabeth ;
Eaby-Sandy, Beth ;
Mutale, Faith ;
DiLullo, Gloria ;
Cohen, Roger B. ;
Vachani, Anil ;
Langer, Corey J. .
LUNG CANCER, 2017, 106 :1-7
[3]   PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer [J].
Bocanegra, Ana ;
Fernandez-Hinojal, Gonzalo ;
Zuazo-Ibarra, Miren ;
Arasanz, Hugo ;
Jesus Garcia-Granda, Maria ;
Hernandez, Carlos ;
Ibanez, Maria ;
Hernandez-Marin, Berta ;
Martinez-Aguillo, Maite ;
Jose Lecumberri, Maria ;
Fernandez de Lascoiti, Angela ;
Teijeira, Lucia ;
Morilla, Idoia ;
Vera, Ruth ;
Escors, David ;
Kochan, Grazyna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
[4]   Biomarkers for Clinical Benefit of immune Checkpoint inhibitor Treatment-A Review From the Melanoma Perspective and Beyond [J].
Buder-Bakhaya, Kristina ;
Hassel, Jessica C. .
FRONTIERS IN IMMUNOLOGY, 2018, 9
[5]   Hyperprogressive disease: recognizing a novel pattern to improve patient management [J].
Champiat, Stephane ;
Ferrara, Roberto ;
Massard, Christophe ;
Besse, Benjamin ;
Marabelle, Aurelien ;
Soria, Jean-Charles ;
Ferte, Charles .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (12) :748-762
[6]   Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 [J].
Champiat, Stephane ;
Dercle, Laurent ;
Ammari, Samy ;
Massard, Christophe ;
Hollebecque, Antoine ;
Postel-Vinay, Sophie ;
Chaput, Nathalie ;
Eggermont, Alexander ;
Marabelle, Aurelien ;
Soria, Jean-Charles ;
Ferte, Charles .
CLINICAL CANCER RESEARCH, 2017, 23 (08) :1920-1928
[7]   Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma [J].
de Coana, Yago Pico ;
Wolodarski, Maria ;
Poschke, Isabel ;
Yoshimoto, Yuya ;
Yang, Yuan ;
Nystrom, Maria ;
Edback, Ulrika ;
Brage, Suzanne Eghyazi ;
Lundqvist, Andreas ;
Masucci, Giuseppe V. ;
Hansson, Johan ;
Kiessling, Rolf .
ONCOTARGET, 2017, 8 (13) :21539-21553
[8]   Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma [J].
Fairfax, Benjamin P. ;
Taylor, Chelsea A. ;
Watson, Robert A. ;
Nassiri, Isar ;
Danielli, Sara ;
Fang, Hai ;
Mahe, Elise A. ;
Cooper, Rosalin ;
Woodcock, Victoria ;
Traill, Zoe ;
Al-Mossawi, M. Hussein ;
Knight, Julian C. ;
Klenerman, Paul ;
Payne, Miranda ;
Middleton, Mark R. .
NATURE MEDICINE, 2020, 26 (02) :193-+
[9]   Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors [J].
Fujisawa, Y. .
BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) :224-225
[10]   PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity [J].
Gato-Canas, Maria ;
Zuazo, Miren ;
Arasanz, Hugo ;
Ibanez-Vea, Maria ;
Lorenzo, Laura ;
Fernandez-Hinojal, Gonzalo ;
Vera, Ruth ;
Smerdou, Cristian ;
Martisova, Eva ;
Arozarena, Imanol ;
Wellbrock, Claudia ;
Llopiz, Diana ;
Ruiz, Marta ;
Sarobe, Pablo ;
Breckpot, Karine ;
Kochan, Grazyna ;
Escors, David .
CELL REPORTS, 2017, 20 (08) :1818-1829